1. Home
  2. STIM vs PFO Comparison

STIM vs PFO Comparison

Compare STIM & PFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.19

Market Cap

140.6M

Sector

Health Care

ML Signal

HOLD

Logo Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

PFO

Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

HOLD

Current Price

$9.05

Market Cap

118.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STIM
PFO
Founded
2003
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
140.6M
118.5M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
STIM
PFO
Price
$1.19
$9.05
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
2.6M
34.8K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
6.51%
EPS Growth
57.25
N/A
EPS
N/A
N/A
Revenue
$52,776,000.00
N/A
Revenue This Year
$11.10
N/A
Revenue Next Year
$11.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$8.01
52 Week High
$4.84
$9.90

Technical Indicators

Market Signals
Indicator
STIM
PFO
Relative Strength Index (RSI) 38.06 35.14
Support Level $0.80 $8.85
Resistance Level $1.55 $9.76
Average True Range (ATR) 0.20 0.09
MACD -0.08 -0.02
Stochastic Oscillator 4.78 14.58

Price Performance

Historical Comparison
STIM
PFO

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

Share on Social Networks: